Norgine

Theravia is a distinguished pharmaceutical company dedicated to the development and commercialization of treatments for rare and neglected diseases. The company focuses on addressing unmet medical needs by creating innovative therapies for hereditary metabolic disorders, hematology-oncology, immunology, and gene cell therapy. Through its commitment to advancing healthcare solutions, Theravia aims to improve the quality of life for patients affected by these conditions.

Lunaphore is a biotechnology company that specializes in advanced tumor analysis through its innovative microfluidic chip technology. This platform enables the rapid extraction of spatial proteomic and transcriptome data from tumors and other tissues, transforming standard assays into multiplex spatial biology applications with a user-friendly interface. Lunaphore's solutions support researchers in fields such as immunology, immuno-oncology, and neurology, facilitating the identification of clinically relevant biomarker signatures. By streamlining the cancer diagnostic process, Lunaphore enhances the efficiency and precision of laboratory and hospital assays, ultimately contributing to improved patient outcomes and advancing therapeutic development.

Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment. Their objective is to create intuitive and accurate gadgets that allow surgeons and radiologists to provide the finest treatment. Sirius Perception uses audio and visual feedback to provide real-time, directional advice for pinpointing tumors

Magentiq Eye Ltd. is a medical device company based in Haifa, Israel, established in 2014. The company specializes in enhancing endoscopic procedures through advanced technologies such as artificial intelligence, deep learning, and computer vision. Its flagship product is the Automatic Polyp Detection System (APDS), which aids physicians during colonoscopy by automatically identifying suspicious polyp locations in real-time or in offline mode on pre-recorded videos. This innovation is designed to improve the accuracy of polyp detection, thereby reducing the miss-rate associated with colonoscopies, which can lead to interval cancer. Given the high volume of colonoscopy procedures performed annually, Magentiq Eye's solutions aim to enhance diagnostic effectiveness, ultimately contributing to better patient outcomes and significant healthcare cost savings. The APDS can be integrated with existing colonoscopy systems or offered as a service to clinics and hospitals, positioning Magentiq Eye as a key player in the medical device industry focused on improving endoscopic practices.

Impress is a company that specializes in invisible orthodontics, focusing on personalized teeth alignment services. It offers comprehensive treatments for various dental issues, including unbalanced bites, crowded teeth, rotations, and interdental spaces. Impress is committed to delivering individualized care through tailored diagnoses and treatment plans for each patient. The company also provides digital monitoring services, allowing patients to track their progress remotely. By combining advanced orthodontic solutions with a patient-centric approach, Impress aims to make dental treatment more accessible and affordable.

Inovus Medical is a company that specializes in designing and manufacturing medical simulation products, primarily aimed at enhancing surgical training. Founded in 2012 and based in Saint Helens, United Kingdom, Inovus produces a range of simulators, including take-home and institutional laparoscopic simulators, which facilitate the training of surgical trainees and residents. Their products cover essential procedures such as laparoscopic appendectomy and cholecystectomy, as well as training tools for critical care and general medicine. By providing accessible and versatile healthcare training equipment, Inovus Medical aims to improve surgical skills and, consequently, the quality of patient care. The company serves its customers through online platforms, making its training solutions widely available.

Magentiq Eye Ltd. is a medical device company based in Haifa, Israel, established in 2014. The company specializes in enhancing endoscopic procedures through advanced technologies such as artificial intelligence, deep learning, and computer vision. Its flagship product is the Automatic Polyp Detection System (APDS), which aids physicians during colonoscopy by automatically identifying suspicious polyp locations in real-time or in offline mode on pre-recorded videos. This innovation is designed to improve the accuracy of polyp detection, thereby reducing the miss-rate associated with colonoscopies, which can lead to interval cancer. Given the high volume of colonoscopy procedures performed annually, Magentiq Eye's solutions aim to enhance diagnostic effectiveness, ultimately contributing to better patient outcomes and significant healthcare cost savings. The APDS can be integrated with existing colonoscopy systems or offered as a service to clinics and hospitals, positioning Magentiq Eye as a key player in the medical device industry focused on improving endoscopic practices.

Alesi Surgical Ltd. is a company based in Cardiff, United Kingdom, specializing in the development and commercialization of laparoscopic surgical smoke handling systems. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, Alesi Surgical focuses on creating products that enhance the safety, efficiency, and outcomes of surgical procedures. Its innovative tools are portable and suitable for both laparoscopic and robot-assisted surgeries, utilizing electrostatic precipitation technology to eliminate surgical smoke and maintain a clear visual field during operations. The company distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia, leveraging its access to experienced surgeons and surgical trainers to identify challenges in surgical procedures and design effective solutions.

ImaginAb, Inc. is a clinical stage biotechnology company specializing in immune oncology imaging and radiopharmaceutical therapy. Founded in 2007 and based in Inglewood, California, the company develops engineered antibody fragments, specifically minibodies, to provide diagnostic imaging solutions and insights into cancer immunotherapy. Its product line includes advanced imaging agents such as the CD8 ImmunoPET™ and PSMA PET, which target specific molecular markers in various cancers, including prostate and immune-oncology. These imaging agents are designed to enhance patient selection and monitor treatment progress, facilitating precision medicine. Currently, ImaginAb's lead candidate, 89Zr crefmirlimab berdoxam, is undergoing Phase II clinical trials and has been licensed by multiple pharmaceutical and biotech companies for use in their immunotherapy clinical trials.

Azanta is a privately-owned specialty pharmaceutical company that focuses on marketing, distributing, and developing treatments for specific medical indications. The company's portfolio includes a range of products such as Amnisure, Cicatridina, Repadina Plus, Cystistat, Flexi-T, Methadone, Oxandrin, Suplasyn, Nimorazole, and Angusta. These products cater to various health needs, including women's health indications and orphan oncology treatments. Azanta aims to provide accessible and effective healthcare solutions for patients with specific medical conditions.

Magentiq Eye Ltd. is a medical device company based in Haifa, Israel, established in 2014. The company specializes in enhancing endoscopic procedures through advanced technologies such as artificial intelligence, deep learning, and computer vision. Its flagship product is the Automatic Polyp Detection System (APDS), which aids physicians during colonoscopy by automatically identifying suspicious polyp locations in real-time or in offline mode on pre-recorded videos. This innovation is designed to improve the accuracy of polyp detection, thereby reducing the miss-rate associated with colonoscopies, which can lead to interval cancer. Given the high volume of colonoscopy procedures performed annually, Magentiq Eye's solutions aim to enhance diagnostic effectiveness, ultimately contributing to better patient outcomes and significant healthcare cost savings. The APDS can be integrated with existing colonoscopy systems or offered as a service to clinics and hospitals, positioning Magentiq Eye as a key player in the medical device industry focused on improving endoscopic practices.

PathoQuest SAS, a spin-off from Institut Pasteur, is a biotechnology company specializing in advanced pathogen detection through metagenomics. The company employs next-generation sequencing (NGS) based testing to provide actionable reports for clinicians, biologists, and quality assurance managers in the biopharmaceutical industry. PathoQuest's proprietary sample preparation methods and extensive database of pathogen genomic information address current limitations in infectious agent detection. Their Viral Safety testing service, aimed at biopharmaceutical companies, has already generated revenue from several major firms, showcasing the company’s innovative approach to molecular diagnostics.

Impress is a company that specializes in invisible orthodontics, focusing on personalized teeth alignment services. It offers comprehensive treatments for various dental issues, including unbalanced bites, crowded teeth, rotations, and interdental spaces. Impress is committed to delivering individualized care through tailored diagnoses and treatment plans for each patient. The company also provides digital monitoring services, allowing patients to track their progress remotely. By combining advanced orthodontic solutions with a patient-centric approach, Impress aims to make dental treatment more accessible and affordable.

SpineGuard is a French medical company focused on the design and production of innovative instruments for spinal surgeries, utilizing its proprietary Dynamic Surgical Guidance (DSG®) technology. This powerful, radiation-free sensing platform enhances the accuracy and safety of skeletal implant placement through real-time audio and visual feedback for surgeons. The company's flagship product, the PediGuard probe, is specifically designed for spine surgery, allowing surgeons to create pilot holes in vertebrae with precision. Equipped with a sensor that measures electrical conductivity, the PediGuard alerts surgeons to changes in bone and tissue types without the need for X-ray imaging. Available in various shapes and sizes, these devices cater to a wide range of surgical needs, from pediatric deformity corrections to adult degenerative conditions. With over 80,000 successful spinal procedures supported by PediGuard and substantial clinical evidence backing its efficacy, SpineGuard aims to address critical challenges in pedicle screw placement while improving patient outcomes and operational efficiency in the surgical environment.

Magentiq Eye Ltd. is a medical device company based in Haifa, Israel, established in 2014. The company specializes in enhancing endoscopic procedures through advanced technologies such as artificial intelligence, deep learning, and computer vision. Its flagship product is the Automatic Polyp Detection System (APDS), which aids physicians during colonoscopy by automatically identifying suspicious polyp locations in real-time or in offline mode on pre-recorded videos. This innovation is designed to improve the accuracy of polyp detection, thereby reducing the miss-rate associated with colonoscopies, which can lead to interval cancer. Given the high volume of colonoscopy procedures performed annually, Magentiq Eye's solutions aim to enhance diagnostic effectiveness, ultimately contributing to better patient outcomes and significant healthcare cost savings. The APDS can be integrated with existing colonoscopy systems or offered as a service to clinics and hospitals, positioning Magentiq Eye as a key player in the medical device industry focused on improving endoscopic practices.

Nuubo Smart Solutions Technologies, SL is a Spanish medical device company based in Madrid that specializes in the design and manufacture of wearable wireless technologies for cardiac monitoring. The company has developed a unique system known as the nECG DYNAMIC PLATFORM, which includes a biomedical garment that captures electrocardiogram (ECG) signals without disrupting the user's daily activities. This garment works in conjunction with a wireless device that continuously records and transmits the ECG data for real-time processing. Additionally, Nuubo offers analysis and visualization software that utilizes artificial intelligence algorithms to interpret the collected information. Their innovative approach enables non-invasive, long-term heart monitoring, making it suitable for use by professional sports teams and hospitals. Founded in 2005, Nuubo aims to enhance cardiac prevention, diagnosis, and rehabilitation through its advanced technological solutions.

Pritidenta is a manufacturer specializing in digital dental prosthetic materials. It produces high-quality zirconia multidiscs and next-generation ceramics designed for efficient manufacturing processes using CAD/CAM technology. Their product range caters to various dental applications, including crowns, bridges, veneers, inlays, and onlays, serving the rapidly growing CAD/CAM and 3D printing segments of the dental market.

Caresyntax Inc. is a Boston-based company that provides a digital surgery platform to enhance surgical performance in hospitals and ambulatory surgical centers. Founded in 1991, it leverages data from over 1,600 hospitals globally to deliver insights that improve patient outcomes and operational efficiency. The platform integrates various data sources, including video, audio, clinical, and operational data, enabling real-time analysis and decision-making during surgeries. Caresyntax offers solutions such as qvident, a performance management software, and PRIME365, a comprehensive integration platform that consolidates surgical data and content. With a focus on automating workflows and reducing surgical variability, Caresyntax supports over 4,000 operating rooms and has facilitated millions of surgical procedures worldwide. The company’s HIPAA-compliant software can be deployed on-premise, in the cloud, or in a hybrid format, making it adaptable to diverse healthcare environments.

EBS Technologies GmbH, founded in 2007 and headquartered in Hennigsdorf, Germany, specializes in developing and commercializing medical devices aimed at treating neurologically induced impairments, particularly visual field loss. The company offers EBS Therapy, a non-invasive optic nerve stimulation treatment that utilizes low-voltage electrical currents to promote neuroregeneration and neuroprotection. This therapy targets conditions resulting from stroke, traumatic brain injury, and glaucoma, among others. With over 15 years of research and clinical experience involving more than 1,200 patients, EBS Technologies has demonstrated through double-blind, randomized studies and clinical observations that its therapy can help partially restore vision in affected individuals. The company received the CE Mark for its stimulation device in 2013 and commenced commercial treatments in 2014. Currently, there are eight EBS Treatment centers operating across Germany, with plans to expand the network further.

Merus Labs International Inc., based in Toronto, Canada, is a specialty pharmaceutical company that owns, markets, and distributes a portfolio of products primarily in Europe and Canada. Its product range includes treatments for cardiovascular diseases, overactive bladder, women's health, anemia, parasitic infections, and various other conditions. The company's business model revolves around acquiring and optimizing legacy pharmaceutical products, with a focus on women's health, cardiovascular health, urology, and infectious diseases. Merus Labs operates as a subsidiary of Norgine B.V.

Collagen Solutions plc is a London-based company that specializes in sourcing, developing, manufacturing, and supplying medical-grade collagen components and biomaterials. Their products are utilized in various applications including regenerative medicine, medical devices, and in-vitro diagnostics across global markets such as Europe, North America, and Asia. The company offers a diverse range of collagen formulations, including soluble collagen, collagen powders, and gels, catering to fields such as orthopaedics, sports medicine, dental care, and cardiovascular surgeries. Additionally, Collagen Solutions provides contract manufacturing services, encompassing technology transfer and regulatory support for collagen-based products. Their expertise extends to creating personalized medical-grade bovine collagen for use as tissue scaffolds in reconstructive and wound care procedures. Established in 2013, Collagen Solutions serves a variety of pharmaceutical and medical device companies, fostering long-term commercial relationships through its comprehensive support and product offerings.

PulseCath is a medical device company focused on developing, manufacturing, and marketing circulatory support systems for cardiologists and cardiac surgeons both in the Netherlands and internationally. The company specializes in advanced technologies designed to assist the heart's pumping functions in patients with heart failure. Its flagship product, the iVAC 3L, is a minimal heart circulatory assist device capable of generating up to three liters of blood flow per minute. This device provides critical hemodynamic support during high-risk procedures, such as left ventricular failure management and post-cardiotomy weaning complications. By enabling insertion through the femoral artery, PulseCath's technology allows medical professionals to offer reliable life support to patients in need.

SpineVision S.A. is a spinal technology company that specializes in the design, development, and marketing of implants and instrumentation for spinal treatment. Founded in 1999 and headquartered in Antony, France, the company has subsidiaries in Belgium, Italy, the United Kingdom, and the United States. SpineVision's product offerings include a range of systems addressing various spinal pathologies, such as lumbar degenerative disc diseases, deformities, cervical disorders, trauma, and tumors. Notable products include the Flex+ stabilization system, the X-PLUS spine system, and the LUMIS range for lumbar degenerative conditions. The company collaborates with leading neurological and orthopedic surgeons, resulting in over 20 patents that enhance its innovative capabilities. SpineVision aims to provide effective solutions that improve patient outcomes in spinal treatment.

Q3 Medical Devices Limited is an Irish holding company established in 2013, based in Dublin, with operational presence in Germany. The company, through its subsidiaries, focuses on the development, manufacturing, and distribution of minimally invasive medical devices aimed at treating coronary, peripheral vascular, and non-vascular diseases. It was founded by a global coalition of entrepreneurs, manufacturers, distributors, and medical professionals, all dedicated to enhancing the medical device industry. Q3 Medical Devices targets acquisitions of businesses with annual revenues between 1 and 10 million, specifically in areas that augment its manufacturing capabilities, broaden distribution channels, and expand its product offerings in minimally invasive treatments.

SpineVision S.A. is a spinal technology company that specializes in the design, development, and marketing of implants and instrumentation for spinal treatment. Founded in 1999 and headquartered in Antony, France, the company has subsidiaries in Belgium, Italy, the United Kingdom, and the United States. SpineVision's product offerings include a range of systems addressing various spinal pathologies, such as lumbar degenerative disc diseases, deformities, cervical disorders, trauma, and tumors. Notable products include the Flex+ stabilization system, the X-PLUS spine system, and the LUMIS range for lumbar degenerative conditions. The company collaborates with leading neurological and orthopedic surgeons, resulting in over 20 patents that enhance its innovative capabilities. SpineVision aims to provide effective solutions that improve patient outcomes in spinal treatment.

Azanta is a privately-owned specialty pharmaceutical company that focuses on marketing, distributing, and developing treatments for specific medical indications. The company's portfolio includes a range of products such as Amnisure, Cicatridina, Repadina Plus, Cystistat, Flexi-T, Methadone, Oxandrin, Suplasyn, Nimorazole, and Angusta. These products cater to various health needs, including women's health indications and orphan oncology treatments. Azanta aims to provide accessible and effective healthcare solutions for patients with specific medical conditions.

Agendia, Inc., established in 2003 and headquartered in Irvine, California, specializes in developing and distributing genomic-based diagnostic kits for cancer patients. The company's molecular diagnostic technology analyzes the complete human genome to provide physicians with crucial information about a patient's cancer, enabling personalized treatment plans. Agendia's breast cancer tests, for instance, help assess individual risk for metastasis and guide decisions on chemotherapy, hormonal therapy, or alternative treatments, thereby improving patient outcomes and reducing healthcare costs.

SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.

Stanmore Implants Worldwide Ltd., established in 1949, specializes in designing and manufacturing orthopedic implant systems for both juvenile and adult patients. The company focuses on orthopedic oncology, complex primary and revision cases in the upper limb, lower limb, and pelvis. Its product portfolio includes modular implant systems like METS, patient-specific implants, and extendible prostheses for limb-sparing and complex joint replacement. Stanmore Implants also offers a custom implant service and has a strategic partnership with WebOps LLC. The company, headquartered in Elstree, UK, operates as a subsidiary of Stryker Corporation.

Internis Pharmaceuticals Ltd. is a pharmaceutical company based in London, United Kingdom, specializing in the development, manufacture, and supply of prescription vitamin D medicines. Founded in 2010, the company offers a range of products, including FULTIUM-D3 in various dosages and forms, as well as ACCRETE-D3, which combines calcium and vitamin D3. These medications are designed for the prevention and treatment of common bone disorders, such as osteoporosis and vitamin D deficiency, which affects a significant portion of the UK population. Internis Pharmaceuticals focuses on providing effective solutions for healthcare professionals and patients, addressing the health risks associated with low vitamin D levels, including bone deformities and various health complications. The company operates as a subsidiary of Stada UK Holdings Ltd.

SpineGuard is a French medical company focused on the design and production of innovative instruments for spinal surgeries, utilizing its proprietary Dynamic Surgical Guidance (DSG®) technology. This powerful, radiation-free sensing platform enhances the accuracy and safety of skeletal implant placement through real-time audio and visual feedback for surgeons. The company's flagship product, the PediGuard probe, is specifically designed for spine surgery, allowing surgeons to create pilot holes in vertebrae with precision. Equipped with a sensor that measures electrical conductivity, the PediGuard alerts surgeons to changes in bone and tissue types without the need for X-ray imaging. Available in various shapes and sizes, these devices cater to a wide range of surgical needs, from pediatric deformity corrections to adult degenerative conditions. With over 80,000 successful spinal procedures supported by PediGuard and substantial clinical evidence backing its efficacy, SpineGuard aims to address critical challenges in pedicle screw placement while improving patient outcomes and operational efficiency in the surgical environment.

Medical Vision AB is a medical technology company focused on enhancing visualization during endoscopic surgeries. The firm specializes in the development, construction, and production of medical devices specifically for arthroscopic procedures. Its product offerings include arthro-tube products, arthroscopy pumps, arthroscopy sets, receptacles, digital camera systems, capture devices, fluid management systems, and double pumps. By providing tools that allow for controlled pressure and fluid flow during joint procedures, Medical Vision aims to support healthcare professionals in delivering improved patient care while also promoting cost efficiency in healthcare.